Across TCGA pan-cancer cohorts, TRAJ28 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of TRAJ28’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where TRAJ28 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRAJ28 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
STAD, THCA, and KICH are the cancer types where TRAJ28 tumor–normal differential expression is most reproducible.